Interferon (IFN) receptor mRNA expression patterns in the liver have been shown to correlate with the effectiveness of IFN therapy in patients with hepatitis C virus (HCV) infection. However, it is not clear to what extent this factor contributes to the short (primary)-and long (sustained)term resul
SNPs in the promoter region of the osteopontin gene as a marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C
β Scribed by Masashi Naito; Atsushi Matsui; Mie Inao; Sumiko Nagoshi; Makoto Nagano; Nobuko Ito; Tohru Egashira; Michie Hashimoto; Shunji Mishiro; Satoshi Mochida; Kenji Fujiwara
- Book ID
- 106179716
- Publisher
- Springer Japan
- Year
- 2005
- Tongue
- English
- Weight
- 160 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0944-1174
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract It has been reported that genetic polymorphisms near the __IL28B__ gene or amino acid substitutions in hepatitis C virus (HCV) core protein are associated with the clinical outcome of peginterferon (PEGβIFN) and ribavirin combination therapy. The impact of these factors on the pure sens
## Abstract The interferon sensitivityβdetermining region (ISDR) is useful as a predictive marker of the response to interferon (IFN) therapy for chronic hepatitis patients with a Japanβspecific subtype (Jβtype) of hepatitis C virus (HCV) genotype 1b. This marker is not useful for predicting respon